2025-06-03-Bernstein-奥克塔公司（OKTA）_Okta_（OKTA）_cRPO覆盖范围_是否表明疲软_或许并非如此_13页_458kb

Okta Inc. Investment Analysis Summary

Rating & Price Target

• Outperform Rating by Peter Weed, Bernstein Research, with a Price Target of $132.00 (indicating 26% upside from closing price of $104.73).
• No change to models or investment recommendation.

Key Points

1. Post-Earnings Reactions: Okta’s stock dropped ~15% due to:

   • Thinner Q1 revenue beat (vs. market expectations).
   • No FY forward guidance, implying potential revenue coverage risks.
   • Company attempted to mitigate concerns by re-emphasizing stable demand and no major deal slippages.

2. cRPO Coverage Analysis:

   • Initial reactions viewed declining cRPO coverage negatively, but this was misinterpreted.
   • The decline reflects natural lapping of 3-year contracts: stronger growth was masked by weaker denominator from initial seat buys/sells post-COVID, which are now being "diluted" as contracts mature.
   • Coverage peaked in Q4 FY23 and will normalize by FY25, as the bulk of "down-sells" are reconciled.

3. Macro Headwinds:

   • Revenue guidance conservatism includes $25-30MM ARR potential headwinds from U.S. Federal government spending cuts (DOGE-like effect).
   • Though acknowledged, this was deemed a reasonable assumption for conservative FY guidance.

Investment Implications

• FCF & EPS Projections: Projected FCF and EPS are stable, with significant growth expected from 2025 onwards.
• Valuation Metrics: Maintained at Adjusted P/E of 37x (2025A), EV/FCF of 22.7x (2025A).
• No change in investment stance despite near-term stock volatility, driven by confidence in medium-to-long-term recovery.

Financial Highlights

• Revenue Growth: ~14% YoY (from 2024FY to 2025).
• Net Income: Surged to $1.58B in 2026E from negative losses in prior years.
• ARR Impact: cRPO coverage peaks and gradually normalizes by FY25, signifying stabilized business.

Conclusion

Bernstein maintains an Outperform rating and $132 price target, affirming Okta’s resilience under temporary guidance caution and macro headwinds. The metric cRPO coverage reflects, rather than hinders, the natural co-cycle of business growth and contract maturity.